Endothelin receptor inhibition with bosentan delays onset of liver injury in streptozotocin-induced diabetic condition
{{output}}
Background: This study was designed to investigate the protective effects of bosentan an orally active non-peptide mixed ETA/ETB receptor antagonist, on liver injury in streptozotocin-induced diabetic rats. ... ...
